Table 2.
Sample | n | Isotope Ratio (% ± SD) |
Mole % Excess (% ± SD) |
Nitrate Concentration (mmol/L ± SD) |
CV (%) |
---|---|---|---|---|---|
Intra-run repeatability | |||||
Aqueous standard* | 10 | 10.34 ± 0.30 | - | - | 1.13 |
Aqueous standard 10.5 mole % excess |
10 | - | 10.79 ± 0.45 | - | 1.59 |
Saliva* | 10 | 10.71 ± 0.03 | - | - | 0.30 |
Saliva (a) | 10 | - | - | 0.88 ± 0.004 | 0.46 |
Urine (a) | 10 | - | - | 1.98 ± 0.008 | 0.44 |
Inter-run repeatability | |||||
Saliva* | 6 | 10.64 ± 0.09 | - | - | 0.83 |
Saliva (a) | 6 | 67.15 ± 0.51 | 36.12 ± 0.24 | 0.88 ± 0.008 | 0.90 |
Urine (a) | 6 | 35.52 ± 0.22 | 19.95 ± 0.20 | 2.01 ± 0.017 | 0.87 |
Urine (b) | 6 | 45.58 ± 0.33 | 25.91 ± 0.26 | 1.43 ± 0.013 | 0.94 |
Injection volume | |||||
Aqueous standard* | 6 | 10.38 ± 0.29 | |||
Saliva (a) | 6 | 67.7 ± 0.51 | 36.46 ± 0.20 | 0.87 ± 0.008 | |
Saliva (b) | 6 | 56.16 ± 0.58 | 31.43 ± 0.27 | 1.09 ± 0.014 | |
Urine (a) | 6 | 35.58 ± 0.73 | 20.17 ± 0.47 | 1.98 ± 0.057 | |
Urine (b) | 6 | 48.50 ± 3.24 | 27.60 ± 1.68 | 1.32 ± 0.108 | |
2-fold serial dilution | |||||
Aqueous standard* | 15 | 10.45 ± 0.05 | - | - | |
2mmol/l Aqueous standard |
15 | 61.59 ± 0.20 | 33.89 ± 0.09 | 1.95 ± 0.01 | |
Saliva (a) | 15 | 67.18 ± 0.33 | 36.25 ± 0.13 | 0.88 ± 0.005 | |
Saliva (b) | 15 | 55.60 ± 0.18 | 31.17 ± 0.08 | 1.11 ± 0.008 | |
Urine (a) | 15 | 35.81 ± 0.21 | 20.32 ± 0.65 | 1.96 ± 0.014 | |
Urine (b) | 15 | 45.00 ± 0.14 | 25.76 ± 0.08 | 1.44 ± 0.013 |
All values are expressed as Mean ± SD; all samples and standards were spiked with 0.1mmol/L Na15NO3 unless stated
natural abundance.